By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ
CureVac’s vaccine performed poorly in a clinical trial, in part because of virus variants.
By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ
Related Posts:
Even Without Symptoms, Wuhan Coronavirus May Spread, Experts Fear- Wuhan Coronavirus Looks Increasingly Like a Pandemic, Experts Say
- Inundated With Flu Patients, U.S. Hospitals Brace for Coronavirus
- An Alzheimer’s Drug Trial Fails: ‘We Don’t Have Anything Now’
- New Report on 138 Coronavirus Cases Reveals Disturbing Details
0 comments:
Post a Comment